Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Illumina, Inc. ILMN

Healthcare  —  Diagnostics & Research
270.00 (3.90) (1.42%) as of 25 Sep
Market cap
$41.3B
P/E
50.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Illumina, Inc. (ILMN) P/B ratio

As of 25 September 2026, Illumina, Inc. (ILMN) trades at a P/B ratio of 14.5×. Over the past ten years it has ranged from 2.4× (November 2023) to 19.0× (June 2015); the current reading is higher than 92% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 7.5× (16.62%)
FY2024 9.0× 143.21%
FY2023 3.7× (20.81%)
FY2022 4.6× (10.06%)
FY2021 5.2× (54.14%)
FY2020 11.3× 9.61%
FY2019 10.3× (7.81%)
FY2018 11.2× (3.63%)
FY2017 11.6× 40.12%
FY2016 8.3× (43.60%)

Quarterly

Period P/B ratio Change
Jun 2026 9.4× 32.75%
Mar 2026 7.0× (5.61%)
Dec 2025 7.5× 22.34%
Sep 2025 6.1× (8.01%)
42 more quarters

Against its own ten years

Low 2.4× High 19.0×
Ten-year median 10.0×
Current reading's percentile 92

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
WAT Waters Corporation compare 2.8×
DGX Quest Diagnostics Incorporated compare 3.4×
A Agilent Technologies, Inc. compare 6.6×
IQV IQVIA Holdings Inc. compare 7.1×
ILMN Illumina, Inc. 14.5×
IDXX IDEXX Laboratories, Inc. compare 25.4×
NTRA Natera, Inc. compare 32.5×
MTD Mettler-Toledo International, Inc. compare 2,372×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ILMN